Abvc Biopharma (ABVC) Inventory Average (2015 - 2025)
Abvc Biopharma's (ABVC) quarterly Inventory Average came in at $11460.0 in Q3 2025, little changed on a QoQ basis from $11460.0 in Q2 2025.
Abvc Biopharma (ABVC) Inventory Average (2015 - 2025) Analysis & Trends
Abvc Biopharma (ABVC) has 5 years of Inventory Average data on file, last reported at $11460.0 in Q3 2025.
- Quarterly Inventory Average changed N/A year-over-year to $11460.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $11460.0 (changed N/A YoY) and the FY2015 annual result came in at $534.5, changed N/A from the prior year.
- Inventory Average held at $11460.0 in Q3 2025, from $11460.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $42991.0 in Q4 2021 to a low of $11460.0 in Q2 2025.
- A 3-year average of $22283.0 and a median of $21724.8 in 2022 frame the typical range for Inventory Average.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Abvc Biopharma | 23.34 Mn | 23.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11,460.00 |
| Jun 30, 2025 | 11,460.00 |
| Sep 30, 2022 | 21,172.00 |
| Jun 30, 2022 | 22,277.50 |
| Mar 31, 2022 | 24,337.50 |
| Dec 31, 2021 | 42,991.00 |
| Jun 30, 2019 | 389.50 |
| Mar 31, 2019 | 919.50 |
| Dec 31, 2015 | 274.00 |